(13) RANKL promotes osteoclast formation and activity, whereas OPG acts as a decoy receptor, inhibiting this process and protecting against bone loss
In a mouse study, selenium supplementation increased the expression of certain glutathione enzymes as well as increasing their activity
TB-500 makes more sense when: The injury is deep or hard to reach with an injection (spine, deep hip, cardiac tissue) You're dealing with multiple injuries at the same time Recovery involves systemic inflammation rather than something localized BPC-157 makes more sense when: The injury is easy to inject near (knee, shoulder, elbow, ankle) Gut healing is the main goal, since BPC-157's strongest documented effects are in the GI tract You're targeting a neurological issue through a localized administration route Neither peptide has human RCT data for musculoskeletal use yet
In trials of other GLP-1 medications, people who stopped suddenly without having built supporting habits regained much of the weight, so we recommend building habits during treatment and reducing the dose gradually rather than stopping abruptly
Manufactured peptides have not been reviewed by the FDA for safety or effectiveness